Deciphera Pharmaceuticals Appoints Tucker Kelly As Chief Financial Officer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, a clinical-stage biotechnology company focused on advanced kinase inhibitor treatments targeting the tumor cell and the tumor microenvironment, today announced the appointment of Tucker Kelly as Chief Financial Officer. Mr. Kelly brings over 18 years of financial leadership and strategic management experience to Deciphera.

Help employers find you! Check out all the jobs and post your resume.